- Home
- LOCO vs HRTX Comparison
LOCO vs HRTX Comparison
Compare LOCO & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOCO
- HRTX
- Stock Information
- Founded
- LOCO 1980
- HRTX 1983
- Country
- LOCO United States
- HRTX United States
- Employees
- LOCO N/A
- HRTX N/A
- Industry
- LOCO Restaurants
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- LOCO Consumer Discretionary
- HRTX Health Care
- Exchange
- LOCO Nasdaq
- HRTX Nasdaq
- Market Cap
- LOCO 323.7M
- HRTX 276.1M
- IPO Year
- LOCO 2014
- HRTX 1987
- Fundamental
- Price
- LOCO $10.63
- HRTX $1.35
- Analyst Decision
- LOCO Buy
- HRTX Strong Buy
- Analyst Count
- LOCO 2
- HRTX 2
- Target Price
- LOCO $18.00
- HRTX $4.50
- AVG Volume (30 Days)
- LOCO 175.1K
- HRTX 2.6M
- Earning Date
- LOCO 10-30-2025
- HRTX 08-08-2025
- Dividend Yield
- LOCO N/A
- HRTX N/A
- EPS Growth
- LOCO N/A
- HRTX N/A
- EPS
- LOCO 0.85
- HRTX N/A
- Revenue
- LOCO $479,690,000.00
- HRTX $149,694,000.00
- Revenue This Year
- LOCO $6.29
- HRTX $10.62
- Revenue Next Year
- LOCO $1.56
- HRTX $12.99
- P/E Ratio
- LOCO $12.53
- HRTX N/A
- Revenue Growth
- LOCO 1.85
- HRTX 9.78
- 52 Week Low
- LOCO $8.29
- HRTX $1.04
- 52 Week High
- LOCO $14.10
- HRTX $2.68
- Technical
- Relative Strength Index (RSI)
- LOCO 52.39
- HRTX 36.48
- Support Level
- LOCO $10.40
- HRTX $1.33
- Resistance Level
- LOCO $10.74
- HRTX $1.43
- Average True Range (ATR)
- LOCO 0.26
- HRTX 0.07
- MACD
- LOCO 0.04
- HRTX 0.02
- Stochastic Oscillator
- LOCO 75.57
- HRTX 45.45
About LOCO El Pollo Loco Holdings Inc.
El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. Restaurant locations are typically free-standing and include drive-thrus, and menus include many low-priced options. Poultry is the company's largest food cost, accounting for roughly 38% of total food and paper cost, and the company manages that commodity price risk by using multiple suppliers and entering supply contracts of varying lengths depending on market conditions.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.